Nanobiotechnology

Microspheres and nanoparticles for peptide delivery.

Presented by: Bachem

Speakers: Jyothi Thundimadathil, and Laura Milbrandt

Content

Delivery of peptides is a challenging task due to their low stability to proteolytic enzymes, large size and poor penetration into cells. The major innovation in this field is based on the formulation of microspheres and nanoparticles to encapsulate the peptide to improve its bioavailability and therapeutic efficacy.

Microparticle formulation has been successfully applied in a number of commercial products containing peptides as active pharmaceutical ingredients. The use of nanoparticles to deliver proteins and peptides is still at an early stage of development and is expected to mature in the near future.

To learn more about how Bachem is part of this technology to achieve successful API formulation, watch our webinar on the benefits and challenges of microspheres and nanoparticles for peptide delivery. 

 

About Bachem:
Based in Switzerland, Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides. As a full-service provider, Bachem offers products for clinical development and commercial applications, as well as a comprehensive catalog and exclusive custom synthesis.